Current concepts on coronary revascularization in diabetic patients
Diabetic mellitus (DM) patients with coronary artery disease (CAD) are at higher risk of cardiovascular events compared with non-DM individuals. While aggressive cardiovascular prevention and adequate blood glucose control remain cornerstones of therapy, the decision when and how to proceed to coronary revascularization in an individual DM patient should be based on the extent of CAD, ischaemic burden, ventricular function, as well as comorbidities. While in patients with stable symptoms, moderate CAD on coronary angiography and preserved left ventricular function a conservative strategy may be a valuable initial strategy, in patients with acute coronary syndromes (ACS) an early invasive approach should be favoured. The revascularization strategy for DM patients with complex multivessel CAD should be discussed within a heart team consisting of cardiologists, cardiac surgeons, and anaesthesiologists. In general, the threshold for coronary artery bypass surgery (CABG) should be lower for DM than for non-DM individuals. In patients undergoing percutaneous coronary intervention, the use of drug-eluting stents (DES) andin the setting of ACSof potent platelet inhibitors, such as prasugrel or ticagrelor, should be favoured. In the near future, multiple strategies may further favourably impact the prognosis of DM patients undergoing coronary revascularization. These include alternative antiplatelet agents such as thromboxane receptor inhibitors, the broad use of second generation DES, and possibly the implantation of bioresorbable stents. Coronary artery bypass surgery outcomes may also further improve by wide implementation of arterial revascularization, reduction in perioperative stroke by avoiding clamping of the aorta, reduction in wound infection by minimally invasive techniques, and optimization of post-operative medical management.
|Keywords||Acute coronary syndromes, Antiplatelet agents, Clopidogrel, Coronary artery bypass grafting, Diabetes mellitus, Drug-eluting stents, Percutaneous coronary intervention, Prasugrel, Ticagrelor|
|Persistent URL||dx.doi.org/10.1093/eurheartj/ehr305, hdl.handle.net/1765/33608|
Roffi, M., Angiolillo, D.J., & Kappetein, A.P.. (2011). Current concepts on coronary revascularization in diabetic patients. European Heart Journal, 32(22). doi:10.1093/eurheartj/ehr305